Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
| The first 150 words of the full text of this article appear below. |
EDITOR
In my role as a peer programme advisor (infection control, harm
minimisation) and as a drugs and alcohol counsellor at a Melbourne
centre with over 700 patients on methadone and 300 on naltrexone I
wonder at the prison system in Victoria.
We have no maintenance program for methadone, no needle exchange, and do not allow inmates to continue on naltrexone programmes when they enter prison. But we do provide harm minimisation sessions, mandatory HIV and hepatitis sessions, and bleach for injecting equipment.
If we are to go some way towards providing similar medical treatment to
that provided in the community we should at least allow prisoners to
continue on methadone and the more recent naltrexone programmes. Some
of our patients who were taking naltrexone when they entered prison
were denied further treatment. What happens if one of these patients
lapses and we have a death from overdose? Is there not
Read all Rapid Responses